Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.15.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.509ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.293ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.26 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.103 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.29.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.75 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.100 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.44 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621.1 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used